Synflix Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.50 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -56.69%
- Profit Growth 980.46%
- Ebitda -7.06%
- Net Worth 72.88%
- Total Assets 87.75%
About Synflix Pharmaceutical
Synflix Pharmaceutical Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2018 (Six years and 11 months 29 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kannan Sudha and Arunachalam Lakshmi serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2018PTC120841
-
Company No.
120841
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Feb 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Synflix Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kannan Sudha
|
Director | 15-Feb-2018 | Current |
|
Arunachalam Lakshmi
|
Director | 15-Feb-2018 | Current |
Financial Performance of Synflix Pharmaceutical.
Synflix Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.69% decrease. The company also saw a substantial improvement in profitability, with a 980.46% increase in profit. The company's net worth Soared by an impressive increase of 72.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synflix Pharmaceutical?
In 2022, Synflix Pharmaceutical had a promoter holding of 77.78% and a public holding of 22.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synflix Pharmaceutical?
Unlock and access historical data on people associated with Synflix Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synflix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synflix Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
